Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-745087
Filing Date
2016-10-24
Accepted
2016-10-24 16:03:30
Documents
5
Effectiveness Date
2016-10-24

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d269036ds8.htm S-8 383948
2 OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP d269036dex51.htm EX-5.1 9051
3 CONSENT OF CHERRY BEKAERT LLP d269036dex232.htm EX-23.2 1477
4 HEDGEPATH PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN d269036dex991.htm EX-99.1 117388
5 GRAPHIC g269036g1014072217096.jpg GRAPHIC 8611
  Complete submission text file 0001193125-16-745087.txt   525048
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-214207 | Film No.: 161948203
SIC: 8731 Services-Commercial Physical & Biological Research